Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
14 /100
LOW RISK
Score updated Aug 28, 2026

KRYS — Krystal Biotech, Inc. Dilution Risk Tracker

Track KRYS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KRYS — Get alerts when the score changes →

As of August 28, 2026, Krystal Biotech, Inc. (KRYS) has a DilutionWatch DilutionScore of 14/100, rated LOW dilution risk. Krystal Biotech, Inc. has a market capitalization of $9.11B, 29.60M shares outstanding, 370 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for KRYS.
🔔 Track KRYS — Get forecast alerts →

Market Data

Market Cap$9.11B
Shares Outstanding29.60M
Float23.37M
Cash$427.74M
Debt$4.25M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 20.9% shares (2026Q1 vs prior)
370 institutional holders · 35.07M shares
#1 Avoro Capital Advisors LLC 5.78M shares
#2 FMR LLC 4.37M shares
#3 BlackRock, Inc. 3.94M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.20M
Days to Cover4.2
% of Float13.7%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2017-12-31
4 INSIDER TRANSACTION 2026-03-06
3 FORM3 2026-03-06
3 FORM3 2026-03-06
4 INSIDER TRANSACTION 2026-03-03
Full SEC filing analysis available with free account

Recent News

No recent news

Factual KRYS Dilution Snapshot

Krystal Biotech, Inc. (KRYS) has a DilutionScore of 14/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track KRYS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KRYS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KRYS
KRYS FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.